Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 12:45 PM EDT

Bio-Techne (TECH) Income towards Parent Company (2009 - 2026)

Bio-Techne (TECH) posted quarterly Income towards Parent Company of $51.0 million for Q1 2026, up 125.99% year-over-year from $22.6 million in Q1 2025, and up 34.3% quarter-over-quarter from $38.0 million in Q4 2025.

Analysis

Bio-Techne (TECH) Income towards Parent Company (2009 - 2026) Analysis & Trends

Bio-Techne's Income towards Parent Company history runs 18 years deep, the most recent figure standing at $51.0 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 125.99% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $22.7 million (down 71.78% YoY), while the FY2025 annual figure was -$13.4 million, down 111.46% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at $51.0 million, up from $38.0 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $89.7 million in Q3 2022, with the low at -$104.5 million in Q2 2025.
  • The 5-year median for Income towards Parent Company is $49.1 million (2024), against an average of $38.0 million.
  • The sharpest annual moves came in 2022 and 2025: Income towards Parent Company jumped 615.95% in 2022, then slumped 899.35% in 2025.
  • Bio-Techne's Income towards Parent Company stood at $50.0 million in 2022, then plunged by 45.08% to $27.5 million in 2023, then gained by 27.03% to $34.9 million in 2024, then gained by 8.94% to $38.0 million in 2025, then soared by 34.3% to $51.0 million in 2026.
  • Business Quant data shows TECH's Income towards Parent Company at $51.0 million in Q1 2026, $38.0 million in Q4 2025, and $38.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn
10 Bio-Techne 11.30 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.62 Mn
Mar 31, 2026 51.05 Mn
Dec 31, 2025 38.01 Mn
Sep 30, 2025 38.19 Mn
Jun 30, 2025 -68.83 Mn
Mar 31, 2025 22.59 Mn
Dec 31, 2024 34.89 Mn
Sep 30, 2024 33.60 Mn
Jun 30, 2024 427,000.00
Mar 31, 2024 49.06 Mn
Dec 31, 2023 27.47 Mn
Sep 30, 2023 50.99 Mn
Jun 30, 2023 45.69 Mn
Mar 31, 2023 70.22 Mn
Dec 31, 2022 50.01 Mn
Sep 30, 2022 89.73 Mn
Jun 30, 2022 61.92 Mn
Mar 31, 2022 60.14 Mn
Dec 31, 2021 72.06 Mn
Sep 30, 2021 68.98 Mn